Comparative Biosciences, Inc.

Sunnyvale, CA

UEI
NJLNAFJ1A715
CAGE
1VCR8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
786 Lucerne Dr, Sunnyvale, CA 94085, USA
Website
compbio.com
Founded
1996
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Histology/pathology services W91ZLK08P1897 ACC Aberdeen Proving Ground $277,713
MD study, maximum tolerated dose HHSN267200801130P National Institute of Environmental Health Sciences (NIH) $15,450
MD study, maximum tolerated dose; 4T1 metastasis study effect of bewley cmpd on 4T1 breast cancer metastasis HHSN267200801024P National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $24,000

Quick answers

Is Comparative Biosciences, Inc. registered in SAM.gov?

Yes. Comparative Biosciences, Inc.'s SAM.gov registration is active through May 7, 2027.

What is Comparative Biosciences, Inc.'s most recent federal award?

Comparative Biosciences, Inc.'s most recent federal contract award is Histology/pathology services (W91ZLK08P1897), from ACC Aberdeen Proving Ground, on September 30, 2008.

On GovTribe

See Comparative Biosciences, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login